Stocks · Health care · Biological Products, (No Diagnostic Substances)

Solid Biosciences Inc.

SLDB Clue Score20
United States Fiscal year ends December CIK 0001707502 Results filed 6 Mar 2026

What the insiders did Scheduled selling only

By person

12 insiders · 1 transaction
2.0×

Alexander Cumbo holds only 2.0 times base salary in stock. $1.32M of shares against $650.99K in salary for 2025.

Salary from the company's own proxy. The shares are what Alexander Cumbo last reported holding, valued at $5.62, the price Common Stock was last bought or sold at on the open market here, on 19 Oct 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Gabriel Brooks
Chief Medical Officer
—
$24.58K (1) scheduled
−$24.58K
97,241
0.0907%
$546.49K
+379.7%
Perceptive Advisors LLC entity
Director
—
—
—
11,833,539
11.04%
$66.50M
+73.2%
Bain Capital Life Sciences Investors, LLC entity
10% owner
—
—
—
5,034,582
4.70%
$28.29M
+24.8%
Adage Capital Management, L.P. entity
10% owner
—
—
—
4,248,084
3.96%
$23.87M
+6.3%
Alexander Cumbo
President and CEO
—
—
—
235,405
0.2195%
$1.32M
+758.5%
Ian F Smith
Director
—
—
—
141,585
0.1320%
$795.71K
+29.0%
Ilan Ganot
Director
—
—
—
126,771
0.1182%
$712.45K
+20.9%
David T Howton
Chief Operating Officer
—
—
—
105,077
0.0980%
$590.53K
+1,267%
Kevin Tan
CFO & Treasurer
—
—
—
99,422
0.0927%
$558.75K
+283.6%
Jessie Hanrahan
Chief Regulatory Officer
—
—
—
74,318
0.0693%
$417.67K
+964.3%
Paul Herzich
Chief Technology Officer
—
—
—
72,638
0.0677%
$408.23K
+453.5%
Clare Kahn
Director
—
—
—
2,960
0.0028%
$16.64K
+169.1%